PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction
Open Access
- 1 January 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 14 (6), R220
- https://doi.org/10.1186/cc9354
Abstract
Lymphocyte apoptosis and monocyte dysfunction play a pivotal role in sepsis-induced immunosuppression. Programmed death-1 (PD1) and its ligand programmed death ligand-1 (PD-L1) exert inhibitory function by regulating the balance among T cell activation, tolerance, and immunopathology. PD-1 deficiency or blockade has been shown to improve survival in murine sepsis. However, PD-L1 and PD-1 differ in their expression patterns and the role of PD-L1 in sepsis-induced immunosuppression is still unknown. Sepsis was induced in adult C57BL/6 male mice via cecal ligation and puncture (CLP). The expression of PD-1 and PD-L1 expression on peripheral T cells, B cells and monocytes were measured 24 hours after CLP or sham surgery. Additionally, the effects of anti-PD-L1 antibody on lymphocyte number, apoptosis of spleen and thymus, activities of caspase-8 and caspase-9, cytokine production, bacterial clearance, and survival were determined. Expression of PD-1 on T cells, B cells and monocytes and PD-L1 on B cells and monocytes were up-regulated in septic animals compared to sham-operated controls. PD-L1 blockade significantly improved survival of CLP mice. Anti-PD-L1 antibody administration prevented sepsis-induced depletion of lymphocytes, increased tumor necrosis factor (TNF)-α and interleukin (IL)-6 production, decreased IL-10 production, and enhanced bacterial clearance. PD-L1 blockade exerts a protective effect on sepsis at least partly by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Anti-PD-L1 antibody administration may be a promising therapeutic strategy for sepsis-induced immunosuppression.Keywords
This publication has 35 references indexed in Scilit:
- IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in SepsisThe Journal of Immunology, 2010
- IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in SepsisPublished by The American Association of Immunologists ,2009
- PD-1 on dendritic cells impedes innate immunity against bacterial infectionBlood, 2009
- PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsisProceedings of the National Academy of Sciences of the United States of America, 2009
- Lymphocytes, apoptosis and sepsis: making the jump from mice to humansCritical Care, 2009
- The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill PatientsClinics in Chest Medicine, 2008
- Sepsis, apoptosis and complementBiochemical Pharmacology, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungusHistoplasma capsulatumProceedings of the National Academy of Sciences of the United States of America, 2008
- THE CONTRIBUTION OF CD4+ CD25+ T-REGULATORY-CELLS TO IMMUNE SUPPRESSION IN SEPSISShock, 2007